(Q50638983)
Statements
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis (English)
Renea A Taylor
David Clouston
Ania Sliwinski
Sally Hunter
Gillian Mitchell
Declan Murphy
Mark Frydenberg
David Pook
John Pedersen
Roxanne Toivanen
Hong Wang
Melissa Papargiris